The Efficacy of Ibrutinib in Patients With Relapsed Mantle Cell Lymphoma After First Line Intensive Chemo-Immunotherapy and Asct - A Retrospective Study From the LWP-Ebmt
Hematological Oncology - United Kingdom
doi 10.1002/hon.53_2630
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Wiley